Physician profile
Raevti Bole
NPI 1770931453
$10,527.20
in general payments reported to CMS, 2019-2025
12 companies · $1,623 in 2025
The $1,623 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.05 · 2020: $208 · 2022: $1,600 · 2023: $4,265 · 2024: $2,749 · 2025: $1,623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,142 · Travel and Lodging: $3,166 · Education: $328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,142.17 |
| Travel and Lodging | $3,166.15 |
| Education | $327.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $5,619.82 | 2022-2025 | Titan |
| Boston Scientific Corporation | $3,349.48 | 2019-2025 | Ams 700 Cxr Rte Kit, Ams 700 |
| Antares Pharma, INC. | $443.46 | 2022-2024 | Xyosted, Tlando, Nocdurna |
| Procept Biorobotics Corporation | $303.70 | 2024-2025 | Aquabeam System |
| Endo Pharmaceuticals INC. | $256.53 | 2020-2024 | Xiaflex |
| Olympus America INC. | $164.13 | 2023-2025 | Itind System |
| Endo USA, INC. | $155.19 | 2024-2025 | Xiaflex |
| Innovation Technologies INC | $114.93 | 2023 | Irrisept |
| Tolmar, INC. | $47.50 | 2023 | |
| Medtronic, INC. | $40.13 | 2023-2024 | V-Loc 180 |
| Convatec INC. | $17.33 | 2024 | |
| 180 Medical, INC. | $15.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raevti Bole listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.